Office of Global Health Cooperative Agreement for: Global Capacity through International Non-Governmental Organization (NGO) Partnership, 32773-32781 [05-11152]

Agencies

• Centers for Disease Control and Prevention
• DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Federal Register Volume 70, Number 107 (Monday, June 6, 2005)]
[Notices]
[Pages 32773-32781]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-11152]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Office of Global Health Cooperative Agreement for: Global 
Capacity through International Non-Governmental Organization (NGO) 
Partnership

    Announcement Type: New.
    Funding Opportunity Number: PA AA123.
    Catalog of Federal Domestic Assistance Number: 93.067.
    Key Dates: Application Deadline: July 6, 2005.

I. Funding Opportunity Description

    Authority: Section 301 and 307 of the Public Health Service Act, 
[42 U.S.C. Sections 241 and 242(l)], as amended.

    Background: The Centers for Disease Control and Prevention (CDC)'s 
global programs are an essential component of promoting health and 
preventing disease in the United States and abroad, including ensuring 
rapid detection and response to emerging health threats. CDC cannot 
accomplish these efforts alone and therefore seeks to further its work 
and interests through partnerships with other organizations. The Office 
of Global Health seeks to collaborate with an international Non-
Governmental Organization (NGO) in a public-private partnership. 
Working with a NGO with a strong international presence will leverage 
existing resources to achieve health goals. CDC's knowledge and 
abilities as a scientific organization can be effectively joined with 
an international NGO that has demonstrated ability to effectively 
implement public health interventions in many different countries. This 
international NGO's experience in community-based interventions in a 
variety of health topic areas will enable public health science to be 
readily disseminated into the field. The intent of this announcement is 
to enhance collaboration through building a public-private partnership, 
and to create impact in health protection and promotion goals.
    This partnership will focus in two areas: Global Disease Detection 
(GDD) and a selection of the United Nations Millennium Development 
Goals (MDG). The goal of the GDD initiative is to develop national and 
international capacity to better detect and respond to infectious 
disease outbreaks of potential worldwide importance, whether natural or 
intentional. CDC is working to recognize infectious disease outbreaks 
faster, improve the ability to control and prevent outbreaks, and to 
detect emerging microbial threats. Through this cooperative agreement 
CDC intends to work with an international NGO partner to pilot a 
program to increase disease detection and surveillance in non-
traditional or resource poor settings. The goal of this pilot is to 
build disease response and detection capacity in an international NGO 
at the local level through communities, organizations, and the Ministry 
of Health (MOH).
    The Millennium Development Goals (MDG) are a framework of eight 
goals, 18 targets, and 48 measures that were developed by experts from 
the United Nations (UN), the International Monetary Fund (IMF), the 
World Bank, and the Organization for Economic Cooperation and 
Development (OECD). These goals were unanimously adopted by the member 
states of the UN in September 2000 to focus on outcomes that promote 
human development as the key to sustaining social and economic 
progress. Several of these goals target areas of focus for the CDC 
including maternal mortality, environmental health, and early childhood 
health and development. Although the MDGs are visionary in nature, 
projects supported through this cooperative agreement have the 
potential for being antecedent steps toward attaining these goals 
through increased service provision, learning capacity, and 
demonstrated competence. The MDGs are eight goals that outline areas of 
action, 18 targets that further define this involvement, and 48 
indicators that provide measurable benchmarks for interventions. See 
the following UN

[[Page 32774]]

Web site (https://www.un.org/millenniumgoals).
    Purpose: The purpose of this announcement is to create an inter-
institutional relationship between the Centers for Disease Control and 
Prevention (CDC) and an international Non-Governmental Organization 
(NGO) that will serve as a bridge between CDC's public health science 
and the selected grantee's community-based programming in several 
functional areas in multiple countries. This cooperative agreement will 
leverage resources and utilize different knowledge and perspective 
between these two distinctive types of organizations. This announcement 
will also provide a flexible mechanism for synergistic activities.
    This cooperative agreement will leverage capacity in distinct areas 
of: Global Disease Detection (GDD), Perinatal and Maternal Mortality 
Reduction, Safe Water Systems (SWS)/Environmental Health Practices, and 
Early Childhood Health and Development. This collaboration will promote 
innovative solutions in a global partnership with extensive diversity, 
resources, and experience. Initial funding is provided at this time for 
Global Disease Detection and Maternal and Perinatal Mortality Reduction 
activities. Other activities mentioned may be included, pending the 
availability of supplemental funds in the future.
    Initial collaboration and activities will be in support of the 
following goals:
    Global Disease Detection (GDD): This cooperative agreement is in 
support of CDC's Global Disease Detection program and its goals of 
increasing global capacity to prepare for, detect and verify, respond 
to, and recover from naturally occurring and deliberate threats to 
health. This will occur through objectives of strengthening sustainable 
capacity in areas of epidemiology, laboratory, outbreak response, 
disease monitoring, communications, and management.
    Other projects in this announcement are in support of several 
Millennium Development Goals (MDG) including:
    Perinatal and Maternal Mortality Reduction:
    Millennium Development Goal 5: Improve maternal health.
    Target 6: Reduce by three quarters, between 1990 and 2015, the 
maternal mortality ratio.
    Indicator 16: Maternal mortality ratio (United Nations Children's 
Fund--World Health Organization (UNICEF-WHO)).
    Indicator 17: Proportion of births attended by skilled health 
personnel (UNICEF-WHO).
    Safe Water Systems (SWS)/Environmental Health Practice:
    Target 10: Halve, by 2015, the proportion of people without 
sustainable access to safe drinking water and sanitation.
    Indicator 30: Proportion of population with sustainable access to 
an improved water source, urban and rural (UNICEF-WHO).
    Indicator 31: Proportion of population with access to improved 
sanitation, urban and rural (UNICEF-WHO).
    Early Childhood Health and Development:
    Millennium Development Goal 4: Reduce Child Mortality.
    Target 5: Reduce by two thirds, between 1990 and 2015, the under-
five mortality rate.
    Indicator 13: Under-five mortality rate (UNICEF-WHO).
    This announcement is only for non-research activities supported by 
CDC/ATSDR. If research is proposed, the application will not be 
reviewed. For the definition of research, please see the CDC Web site 
at the following Internet address: https://www.cdc.gov/od/ads/
opspoll1.htm.
    Activities: Awardee activities for this program are as follows:
    General: The CDC and the selected grantee will work together to 
develop a long-term relationship, with logistical and multi-sectoral 
outreach and education. This collaboration will establish a clear 
understanding and protocols in areas of this undertaking. The grantee 
must have the ability to work with multiple local country offices to 
link and integrate projects in an international setting and liaison 
with the CDC. Project findings in one country may be translated and 
implemented in other settings; therefore the partnering organization 
must have a worldwide network that includes a resident staff presence 
in at least 60 countries worldwide.
    The selected grantee in collaboration with the CDC will work to 
determine appropriate sites for project implementation. The grantee 
will explore the strategic interests of the country offices and their 
on-the-ground staff, in order to identify the best possible sites for 
collaboration. Once collaboration is established the grantee will move 
from technical assistance to leadership and collaboration with sound 
programming. The grantee will also devote the necessary resources and 
time to monitor and evaluate the impact on the health system and the 
health of the communities targeted. It is also expected that the 
grantee will liaison with other CDC in-country programs in order to 
avoid duplication and to identify areas for collaboration.
    This cooperative agreement will function under the guidance of a 
technical advisory group. As this agreement will cover a variety of 
activities, the selected grantee must nominate a single point of 
contact for all communication and information with CDC in order to 
streamline the development and implementation of this collaboration.
    Initial Funding is provided for the following activities:
    Global Disease Detection (GDD): One focus of this announcement will 
be to create emerging/reemerging disease detection capacity in a major 
international Non-Governmental Organization (NGO) that has resident 
staff in sixty or more countries.
    In general, CDC expectations of the Global Disease Detection (GDD) 
program are to: recognize infectious disease outbreaks faster, improve 
the ability to control and prevent outbreaks, detect emerging microbial 
threats, and to work with global partners. CDC will develop a 
partnership with the chosen grantee to increase disease detection and 
surveillance in non-traditional or resource poor settings. With CDC 
assistance, the grantee will develop preparedness, recognition, and 
response standards and protocols for emerging/re-emerging diseases. 
Although final pilot project sites will be determined in collaboration 
with CDC advisors, initial pilot project areas may include Vietnam and 
India. Therefore, applicants must have a demonstrated capacity in 
Vietnam and India in health and disease prevention.
    Activities conducted under this cooperative agreement include but 
are not limited to:
     Assess current disease detection capacity and public 
health infrastructure in pilot locations and plan resource appropriate 
interventions.
     Develop and improve local early warning systems.
     Enhance collaboration with multinational organizations and 
their partners.
     Create evidence-based tools/practices for emerging/
reemerging diseases that can be realistically implemented in resource 
poor communities.
     Provide standardized GDD criteria for grantee response to 
disease outbreaks.
     Identify areas where coordinated detection and response 
can occur.
     Improve syndromic surveillance capabilities at a local 
level.

[[Page 32775]]

     Assess and utilize, if applicable, existing information 
technology tools and evidence-based best practices to track infectious 
disease outbreaks and their epidemiology.
     Provide approaches that can be simultaneously coordinated 
with ongoing surveillance initiatives--e.g. WHO's Global Outbreak Alert 
Response Network (GOARN).
     Utilize/apply geographic information system (GIS) based 
approaches to outbreak detection.
     Provide realistic ``threshold'' based approaches for 
cluster detection and signal generation for outbreaks.
     Develop plans to implement sustainable collaborations 
between community animal-health workers or veterinary scientists and 
public health agencies involved in human disease outbreak surveillance 
program(s).
     Outline roles of automated laboratory systems/Web-based 
reporting in disease outbreak surveillance programs.
     Identify ways to strengthen local and national laboratory 
capacity.
     Develop information on sources of infection, symptoms, 
prevention techniques, and cross-species dangers.
     Collect, analyze, and interpret data.
     Identify appropriate communication media and messages.
     Develop long-term plans to move beyond the initial 
implementation phase and develop and disseminate interventions to other 
countries.
     Pilot a community-based intervention in the area of 
emerging disease surveillance and detection within a grantee country 
office. Funds will be provided for materials, training, and a workshop 
in this area. It is envisaged that this pilot will occur in Vietnam or 
India in response to concerns regarding avian influenza, or other 
possible emerging/reemerging diseases.
    Perinatal and Maternal Mortality Reduction: This cooperative 
agreement will also focus on perinatal and maternal mortality 
reduction. The focus will be on ensuring quality emergency obstetrics 
care for women, creating strong referral systems in community-based 
health services, improving community-based reproductive health 
programs, and working with communities to address key barriers that 
prevent women from receiving health services related to maternal 
health. CDC's Division of Reproductive Health (DRH) and the Global AIDS 
Program (GAP) will use this cooperative agreement to further 
collaboration with grantees and to streamline their ability to 
implement international projects. The CDC envisages perinatal and 
maternal mortality reduction collaboration to initially begin in the 
countries of: Afghanistan, Tajikistan, Ethiopia, and Tanzania, as well 
as other countries in sub-Saharan Africa. Although final project sites 
will be determined in collaboration between the selected grantee and 
CDC advisors, applicants must have a demonstrated capacity in 
Afghanistan, Tajikistan, Ethiopia, Tanzania, and sub-Saharan Africa in 
this capacity.
    Activities conducted under this cooperative agreement include but 
are not limited to:
     Develop, implement, and evaluate community-based 
approaches, including but not limited to capacity building, empowerment 
and other participatory approaches that promote maternal and child 
health.
     Implement a participatory model of community mobilization; 
examine the capacity of the existing infrastructure to respond to 
reproductive health needs; and address issues identified by communities 
(e.g., assessing the need for maternity waiting homes for the at-risk 
patient).
     Implement maternal and infant health community 
surveillance systems.
     Survey and evaluate special populations, e.g., 
adolescents, refugees and HIV-infected population.
     Analyze and define the parameters of reproductive health 
programs.
     Review quality of care provided in maternal child health 
clinics (e.g., clinic management, patient flow analysis).
     Expand and improve Prevention of Mother to Child HIV 
Transmission (PMTCT) services.

    Note: Other activities may be included in this cooperative 
agreement in the future, pending the availability of funds. Although 
funding may not be available at this time, the selected grantee 
should have the capacity and intent to engage in these future 
activities. Funding may be provided in a supplemental manner for the 
following activities. Following federal protocols this would be 
limited to a total for all supplemental activities of twenty-five 
percent of the total base amount per annum.

    Safe Water Systems (SWS)/Environmental Health Practice:
    The safe water systems/environmental health practice component of 
this announcement will work on several small discrete projects 
determined in cooperation by the CDC and the selected grantee. Projects 
will focus on working to develop the capacity to detect and monitor 
emerging diseases as well as bacterial, foodborne, and waterborne 
illnesses. Collaboration will also include the implementation of point-
of-use interventions including Safe Water System (SWS) approaches and 
SWS trainings in both routine and emergency situations. The grantee may 
expand these activities to include partnering with other organizations 
in hand hygiene and SWS design.
    The selected grantee will also conduct environmental health 
practice projects. These projects may include providing the technical 
assistance and expertise needed to develop sustainable environmental 
health programs to ensure the identification and control of 
environmental conditions contributing to disease. The Community 
Environmental Health Assessment (CEHA) is one such process that builds 
environmental health risk monitoring and develops local environmental 
health capacity. Although final project sites will be determined in 
collaboration between the selected grantee and CDC advisors, initial 
environmental health practice project sites may focus on Latin America.
    Therefore, applicants must have a demonstrated capacity in 
environmental work in Latin America.
    Activities conducted under this area of the cooperative agreement 
include but are not limited to:
     Strengthen collaboration between epidemiology, laboratory, 
and environmental health services to monitor environmental and health 
risks.
     Identify and strengthen local and national laboratory 
capacity.
     Develop strategies to promote and strengthen community 
participation in community-based environmental health and general 
health assessments.
     Develop local environmental health risk monitoring 
systems.
     Strengthen health surveillance activities at the primary 
level in communities.
     Collect, organize, analyze, and interpret health and 
environmental data.
    Early Childhood Health and Development: This cooperative agreement 
will also seek to improve the health and development of orphaned and 
vulnerable preschool-aged children through interventions provided at a 
locally organized and managed daycare center that can be replicated in 
other communities and sustained through community resources. In areas 
of the world heavily impacted by the HIV/AIDS epidemic, young children 
are often part of families in which one or both parents have died. 
Preschool aged children are particularly vulnerable to the lack of 
adequate physical, cognitive, and socioemotional nurturing. With a loss 
of parents, and a breakdown of household structures, many communities 
have resorted to forming daycare centers, run by widows or adolescent 
orphans. If properly staffed

[[Page 32776]]

and resourced, these centers can provide much for attending young 
children including nutrition, developmental stimulation, and emotional 
support. Such nutrition, development, and emotional support can have a 
large impact in the overall health of the child and may impact 
childhood mortality rates. Integrated with the socio-emotional 
development of the child are several health interventions including: 
nutrition, health assessment, deworming (anti-helmentics), and other 
basic health interventions. The goal of this project will be to 
determine whether community daycare centers can provide interventions 
and services that promote the health and development of young children 
in resource-poor settings in a cost-effective and sustainable manner. 
Although final project sites will be determined in collaboration 
between the selected grantee and CDC advisors, an initial project site 
may include Kenya. Therefore, applicants must have a demonstrated 
capacity in Kenya, in education and child development.
    Activities conducted under this cooperative agreement include but 
are not limited to:
     Assess and evaluate the developmental and health status of 
pre-school aged children in HIV/AIDS impacted households in a pilot 
community.
     Evaluate whether developmental and health parameters of 
orphaned and vulnerable children improve with participation in a 
community daycare center.
     Establish a minimum package of interventions in a 
community daycare center, that includes health, cognitive, and 
socioemotional development interventions.
     Determine whether effective interventions for improving 
early childhood development and health can be modified to be delivered 
by minimally trained individuals and can utilize available local 
materials.
     Identify appropriate local partners.
     Conduct evaluation and monitoring of projects, including a 
cost-benefit analysis.
    In a cooperative agreement, CDC staff is substantially involved in 
the program activities, above and beyond routine grant monitoring.
    CDC Activities for this cooperative agreement include, but are not 
limited to:
     Determining project site locations and length of 
implementation.
     Assessing current disease detection capacity and public 
health infrastructure in pilot locations and planning resource 
appropriate interventions.
     Creating evidence-based tools/practices for emerging/
reemerging diseases.
     Developing plans to implement sustainable collaborations 
in human disease outbreak surveillance program(s).
     Identifying ways to strengthen local and national 
laboratory capacity.
     Piloting a Global Disease Detection community-based 
intervention within a grantee country.
     Collaborating on, developing, implementing, training for, 
and integrating perinatal and maternal mortality surveillance systems 
at the local level.
     Training and implementation assistance on Safe Water 
System (SWS) approaches.
     Collaboration in conducting Community Environmental Health 
Assessments (CEHA), and determining appropriate next steps.
     Establishing a minimum package of early childhood health 
and development interventions in a community daycare center.

II. Award Information

    Type of Award: Cooperative Agreement. CDC involvement in this 
program is listed in the Activities Section above.
    Fiscal Year Funds: 2005.
    Approximate Total Funding: $100,000.
    $50,000 for Global Disease Detection and $50,000 for Perinatal and 
Maternal Mortality Reduction.
    Approximate Number of Awards: One.
    Approximate Average Award: $100,000: $50,000 for Global Disease 
Detection Activities and $50,000 for Perinatal and Maternal Mortality 
Reduction Activities. (This amount is for the first budget period and 
includes direct and indirect costs).
    Floor of Award Range: None.
    Ceiling of Award Range: $50,000 for Global Disease Detection and 
$50,000 for Perinatal and Maternal Mortality Reduction Activities (For 
the first 12 month budget period).
    Anticipated Award Date: August 1, 2005.
    Budget Period Length: 12 months.
    Project Period Length: Five years.
    Throughout the project period, CDC's commitment to continuation of 
awards will be conditioned on the availability of funds, evidence of 
satisfactory progress by the recipient (as documented in required 
reports), and the determination that continued funding is in the best 
interest of the Federal Government.

III. Eligibility Information

III.1. Eligible applicants

     Applications may be submitted by public and private 
nonprofit and for profit organizations, and by governments and their 
agencies, such as: Public nonprofit organizations; private nonprofit 
organizations; for profit organizations; small, minority, women-owned 
businesses; universities; colleges; research institutions; hospitals; 
community-based organizations; and faith-based organizations that 
possess the experience and ability to select and manage these projects.

III.2. Cost Sharing or Matching

    Matching funds are not required for this program.

III.3. Other

    If you request a funding amount greater than the ceiling of the 
award range, your application will be considered non-responsive, and 
will not be entered into the review process. You will be notified that 
your application did not meet the submission requirements.
    Special Requirements: Eligible applicants must have a history of 
experience and collaboration in the following areas: Global Disease 
Detection (GDD), Perinatal and Maternal Mortality Reduction, Safe Water 
Systems (SWS)/Environmental Health Practice, and Early Childhood Health 
and Development.
    Applicants must also follow the necessary procurement and grants 
and reporting guidelines established by CDC. In addition, eligible 
applicants will be a legal entity with approval to work, and memoranda 
of understanding (MOUs) with Ministries of Health (MOH) in: Vietnam, 
Afghanistan, Ethiopia, Tajikistan, Tanzania, Kenya, and India. Initial 
areas of collaboration include these countries and therefore the 
grantee must have ten years of experience and legal authority to work 
in these countries. For environmental health practice projects, the 
grantee must also demonstrate environmental capacity in Latin America 
through evidence and history of related environmental projects.
    CDC seeks to expand its global capacity through an NGO partnership 
in an organization that has a strong international presence. Project 
findings in one country may be translated and implemented in other 
settings; therefore the partnering organization must have a worldwide 
network that includes resident staff presence in at least 60 countries 
worldwide.

[[Page 32777]]

    Eligible grantees must also have demonstrated experience working at 
a community-based level in a resource challenged environment including 
experience in settings of extreme poverty and working with 
disenfranchised individuals. Eligible entities must also possess 
surveillance capacity with permanent staff on the ground, including 
capacity at the local, district, and national level.
    In addition for project specific portions, eligible entities must:
    Global Disease Detection (GDD): In addition to previously discussed 
areas, the selected partnering organization must demonstrate 
proficiency in the following areas:
     In-depth knowledge of the domestic situation in the 
selected countries including but not limited to experience in: 
Education, health, and development.
     A broad international knowledge base with global 
experience in areas such as: Health, HIV/AIDS, Emergency Humanitarian 
Assistance, and Education.
     Ability to work with local partners on areas of 
Information, Education, and Communication (IEC) as well as Behavioural 
Change Communication (BCC).
     Ability to identify and implement projects within 
established infrastructure, thus avoiding the creation of a vertical 
program.
     Capacity to carefully assess public health infrastructure 
challenges such as the availability of personnel involved in field 
epidemiology and public health laboratory functioning.
    Perinatal and Maternal Mortality Reduction: In addition to 
previously discussed areas, the selected partnering organization must 
demonstrate proficiency in the following areas:
     Experience operating from a community to health facility, 
rather than a facility to community approach so that the local 
community and its needs and concerns are incorporated from the 
inception of the project.
     Experience in both community organization and health 
promotion in reducing maternal and perinatal mortality and promoting 
women and newborn health.
    Safe Water Systems (SWS)/Environmental Health Practice: In addition 
to previously discussed areas, the selected partnering organization 
must demonstrate proficiency in the following areas:
     Capacity to detect and monitor emerging diseases as well 
as bacterial, foodborne, and waterborne illnesses in settings of 
extreme poverty with disenfranchised individuals.
     Demonstrated experience with SWS in both routine and 
emergency situations.
     Familiarity with the SWS and training other organizations 
and individuals in hand hygiene and SWS.
     Familiarity in designing and implementing SWS.
     Pre-existing agreements to operate in this area with 
necessary local, and regional authorities.
     Experience in strengthening local/regional/national 
environmental health service infrastructure.
     Experience in environmental risk monitoring, and community 
involvement, including building local environmental health capacity.
    Early Childhood Health and Development: In addition to previously 
discussed areas, the selected partnering organization must demonstrate 
proficiency in the following areas:
     Capacity in educational and health programming including 
experience in working in settings of extreme poverty and working with 
disenfranchised individuals.
     Experience working with community-level organizations to 
address educational, health and developmental needs.
     Capacity in addressing the impact of HIV/AIDS on education 
programs.
     Training local caregivers and other organizations in 
education, health, and development.
     Evaluation and monitoring capacity in education, health 
and development.
    If your application is incomplete or non-responsive to the special 
requirements listed in this section, it will not be entered into the 
review process. You will be notified that your application did not meet 
submission requirements.
     Late applications will be considered non-responsive. See 
section ``IV.3. Submission Dates and Times'' for more information on 
deadlines.
     Note: Title 2 of the United States Code Section 1611 
states that an organization described in Section 501(c)(4) of the 
Internal Revenue Code that engages in lobbying activities is not 
eligible to receive Federal funds constituting an award, grant, or 
loan.

IV. Application and Submission Information

IV.1. Address To Request Application Package

    To apply for this funding opportunity use application form PHS 
5161-1.
    Electronic Submission: CDC strongly encourages you to submit your 
application electronically by utilizing the forms and instructions 
posted for this announcement on https://www.Grants.gov, the official 
Federal agency wide E-grant Web site. Only applicants who apply online 
are permitted to forego paper copy submission of all application forms.
    Paper Submission: Application forms and instructions are available 
on the CDC Web site, at the following Internet address: https://
www.cdc.gov/od/pgo/forminfo.htm.
    If you do not have access to the Internet, or if you have 
difficulty accessing the forms on-line, you may contact the CDC 
Procurement and Grants Office Technical Information Management Section 
(PGO-TIM) staff at: 770-488-2700. Application forms can be mailed to 
you.

IV.2. Content and Form of Submission

Application
    Electronic Submission: You may submit your application 
electronically at: https://www.grants.gov. Applications completed online 
through Grants.gov are considered formally submitted when the applicant 
organization's Authorizing Official electronically submits the 
application to https://www.grants.gov. Electronic applications will be 
considered as having met the deadline if the application has been 
submitted electronically by the applicant organization's Authorizing 
Official to Grants.gov on or before the deadline date and time.
    It is strongly recommended that you submit your grant application 
using Microsoft Office products (e.g., Microsoft Word, Microsoft Excel, 
etc.). If you do not have access to Microsoft Office products, you may 
submit a PDF file. Directions for creating PDF files can be found on 
the Grants.gov Web site. Use of file formats other than Microsoft 
Office or PDF may result in your file being unreadable by our staff.
    CDC recommends that you submit your application to Grants.gov early 
enough to resolve any unanticipated difficulties prior to the deadline. 
You may also submit a back-up paper submission of your application. Any 
such paper submission must be received in accordance with the 
requirements for timely submission detailed in Section IV.3. of the 
grant announcement. The paper submission must be clearly marked: 
``BACK-UP FOR ELECTRONIC SUBMISSION.'' The paper submission must 
conform with all requirements for non-electronic submissions. If both 
electronic and back-up paper submissions are received by the deadline, 
the electronic version will be considered the official submission.

[[Page 32778]]

    Paper Submission: If you plan to submit your application by hard 
copy, submit the original and two hard copies of your application by 
mail or express delivery service. Refer to section IV.6. Other 
Submission Requirements for submission address.
    You must submit a project narrative with your application forms. 
The narrative must be submitted in the following format:
     Maximum number of pages: 30. If your narrative exceeds the 
page limit, only the first pages which are within the page limit will 
be reviewed.
     Font size: 12 point unreduced.
     Double spaced.
     Paper size: 8.5 by 11 inches.
     Page margin size: One inch.
     Printed only on one side of page.
     Held together only by rubber bands or metal clips; not 
bound in any other way.
    Your narrative should address activities to be conducted over the 
entire project period, and must include the following items in the 
order listed.
    For Global Disease Detection and Perinatal and Maternal Mortality 
Reduction please provide a Plan, Methods, Objectives, Timeline, 
Participating Staff, Performance Measures, and a Budget Justification. 
This budget justification should be for the first year only and include 
direct as well as indirect costs. The budget justification will not be 
counted in the stated page limit.
    For Safe Water System (SWS)/Environmental Health Practice and Early 
Childhood Health and Development Activities, please provide a brief 
general description (one page per activity) that responds to the 
activities outlined, in the case that funding is provided in the 
future. Please also include evidence of appropriate eligible entity 
criteria.
    For all subject areas, please provide a description of your 
demonstrated international capacity. Additionally, please describe your 
minimum ten years of experience in Kenya, Tanzania, Tajikistan, 
Afghanistan, Ethiopia, Vietnam, and India. Please mention your 
appropriate evidence and capacity in environmental projects in Latin 
America. Emphasis should be placed on your international network, 
including a description on your resident staff in a minimum of sixty 
countries worldwide.
    Additional information may be included in the application 
appendices. The appendices will not be counted toward the narrative 
page limit. This additional information includes: Memoranda of 
Understanding (MOUs) with Ministries of Health, Curriculum Vitaes, 
Resumes, Organizational Charts, Letters of Support, and additional 
reporting requirement information.
    You are required to have a Dun and Bradstreet Data Universal 
Numbering System (DUNS) number to apply for a grant or cooperative 
agreement from the Federal government. The DUNS number is a nine-digit 
identification number, which uniquely identifies business entities. 
Obtaining a DUNS number is easy and there is no charge. To obtain a 
DUNS number, access https://www.dunandbradstreet.com or call 1-866-705-
5711.
    For more information, see the CDC Web site at: https://www.cdc.gov/
od/pgo/funding/pubcommt.htm. If your application form does not have a 
DUNS number field, please write your DUNS number at the top of the 
first page of your application, and/or include your DUNS number in your 
application cover letter.
    Additional requirements that may require you to submit additional 
documentation with your application are listed in section ``VI.2. 
Administrative and National Policy Requirements.''

IV.3. Submission Dates and Times

    Application Deadline Date: July 6, 2005.
    Explanation of Deadlines: Applications must be received in the CDC 
Procurement and Grants Office by 4 p.m. Eastern Time on the deadline 
date. If you submit your application by the United States Postal 
Service or commercial delivery service, you must ensure that the 
carrier will be able to guarantee delivery by the closing date and 
time. If CDC receives your submission after closing due to: (1) Carrier 
error, when the carrier accepted the package with a guarantee for 
delivery by the closing date and time, or (2) significant weather 
delays or natural disasters, you will be given the opportunity to 
submit documentation of the carriers guarantee. If the documentation 
verifies a carrier problem, CDC will consider the submission as having 
been received by the deadline.
    This announcement is the definitive guide on application content, 
submission address, and deadline. It supersedes information provided in 
the application instructions. If your submission does not meet the 
deadline above, it will not be eligible for review, and will be 
discarded. You will be notified that you did not meet the submission 
requirements.
    Electronic Submission: If you submit your application 
electronically with Grants.gov, your application will be electronically 
time/date stamped which will serve as receipt of submission. In turn, 
you will receive an e-mail notice of receipt when CDC receives the 
application. All electronic applications must be submitted by 4 p.m. 
eastern time on the application due date.
    Paper Submission: CDC will not notify you upon receipt of your 
paper submission. If you have a question about the receipt of your 
application, first contact your courier. If you still have a question, 
contact the PGO-TIM staff at: 770-488-2700. Before calling, please wait 
two to three days after the submission deadline. This will allow time 
for submissions to be processed and logged.

IV.4. Intergovernmental Review of Applications

    Executive Order 12372 does not apply to this program.

IV.5. Funding restrictions

    Restrictions, which must be taken into account while writing your 
budget, are as follows:
     Funds may not be used for research.
    International Funding Restrictions:
     Funds may be spent for reasonable program purposes, 
including personnel, travel, supplies, and services. Equipment may be 
purchased if deemed necessary to accomplish program objectives, 
however, prior approval by CDC officials must be requested in writing.
     The costs that are generally allowable in grants to 
domestic organizations are allowable to foreign institutions and 
international organizations, with the following exception: With the 
exception of the American University, Beirut and the World Health 
Organization, Indirect Costs will not be paid (either directly or 
through sub-award) to organizations located outside the territorial 
limits of the United States or to international organizations 
regardless of their location.
     The applicant may contract with other organizations under 
this program; however the applicant must perform a substantial portion 
of the activities (including program management and operations, and 
delivery of prevention services for which funds are required.)
     All requests for funds contained in the budget, shall be 
stated in U.S. dollars. Once an award is made, CDC will not compensate 
foreign grantees for currency exchange fluctuations through the 
issuance of supplemental awards.
     You must obtain annual audit of these CDC funds (program-
specific audit) by a U.S.-based audit firm with international branches 
and current licensure/authority in-country, and in

[[Page 32779]]

accordance with International Accounting Standards or equivalent 
standard(s) approved in writing by CDC.
     A fiscal Recipient Capability Assessment may be required, 
prior to or post award, in order to review the applicant's business 
management and fiscal capabilities regarding the handling of U.S. 
Federal funds.
    HIV Programs (GAP) language that may also be applicable:
     Funds received from this announcement will not be used for 
the purchase of antiretroviral drugs for treatment of established HIV 
infection (with the exception of nevirapine in Prevention of Mother-to-
Child Transmission (PMTCT) cases and with prior written approval), 
occupational exposures, and non-occupational exposures and will not be 
used for the purchase of machines and reagents to conduct the necessary 
laboratory monitoring for patient care.
     No funds appropriated under this act shall be used to 
carry out any program of distributing sterile needles or syringes for 
the hypodermic injection of any illegal drug.
Prostitution and Related Activities
    The U.S. Government is opposed to prostitution and related 
activities, which are inherently harmful and dehumanizing, and 
contribute to the phenomenon of trafficking in persons.
    Any entity that receives, directly or indirectly, U.S. Government 
funds in connection with this document (``recipient'') cannot use such 
U.S. Government funds to promote or advocate the legalization or 
practice of prostitution or sex trafficking. Nothing in the preceding 
sentence shall be construed to preclude the provision to individuals of 
palliative care, treatment, or post-exposure pharmaceutical 
prophylaxis, and necessary pharmaceuticals and commodities, including 
test kits, condoms, and, when proven effective, microbicides. A 
recipient that is otherwise eligible to receive funds in connection 
with this document to prevent, treat, or monitor HIV/AIDS shall not be 
required to endorse or utilize a multisectoral approach to combating 
HIV/AIDS, or to endorse, utilize, or participate in a prevention method 
or treatment program to which the recipient has a religious or moral 
objection. Any information provided by recipients about the use of 
condoms as part of projects or activities that are funded in connection 
with this document shall be medically accurate and shall include the 
public health benefits and failure rates of such use.
    In addition, any recipient must have a policy explicitly opposing 
prostitution and sex trafficking. The preceding sentence shall not 
apply to any ``exempt organizations'' (defined as the Global Fund to 
Fight AIDS, Tuberculosis and Malaria, the World Health Organization, 
the International AIDS Vaccine Initiative or to any United Nations 
agency), but does apply to any non-governmental, non-exempt 
organization entity receiving U.S. Government funds from an exempt 
organization in connection with this document.
    The following definition applies for purposes of this clause:
     Sex trafficking means the recruitment, harboring, 
transportation, provision, or obtaining of a person for the purpose of 
a commercial sex act. 22 U.S.C. 7102(9).
    All recipients must insert provisions implementing the applicable 
parts of this section, ``Prostitution and Related Activities,'' in all 
subagreements under this award. These provisions must be express terms 
and conditions of the subagreement, must acknowledge that compliance 
with this section, ``Prostitution and Related Activities,'' is a 
prerequisite to receipt and expenditure of U.S. Government funds in 
connection with this document, and must acknowledge that any violation 
of the provisions shall be grounds for unilateral termination of the 
agreement prior to the end of its term. Recipients must agree that HHS 
may, at any reasonable time, inspect the documents and materials 
maintained or prepared by the recipient in the usual course of its 
operations that relate to the organization's compliance with this 
section, ``Prostitution and Related Activities.''
    All prime recipients receiving U.S. Government funds (``prime 
recipients'') in connection with this document must certify compliance 
(pending OMB clearance) prior to actual receipt of such funds in a 
written statement referencing this document (e.g., ``[Prime recipient's 
name] certifies compliance with the section, `Prostitution and Related 
Activities.' '') addressed to the agency's grants officer. Such 
certifications by prime recipients are prerequisites to the payment of 
any U.S. Government funds in connection with this document.
    Recipients' compliance with this section, ``Prostitution and 
Related Activities,'' is an express term and condition of receiving 
U.S. Government funds in connection with this document, and any 
violation of it shall be grounds for unilateral termination by HHS of 
the agreement with HHS in connection with this document prior to the 
end of its term. The recipient shall refund to HHS the entire amount 
furnished in connection with this document in the event it is 
determined by HHS that the recipient has not complied with this 
section, ``Prostitution and Related Activities.''
Other
    If you are requesting indirect costs in your budget, you must 
include a copy of your indirect cost rate agreement. If your indirect 
cost rate is a provisional rate, the agreement should be less than 12 
months of age.
    Guidance for completing your budget can be found on the CDC Web 
site, at the following Internet address: https://www.cdc.gov/od/pgo/
funding/budgetguide.htm.

IV.6. Other Submission Requirements

Application Submission Address

    Electronic Submission: CDC strongly encourages applicants to submit 
electronically at: https://www.Grants.gov. You will be able to download 
a copy of the application package from https://www.Grants.gov, complete 
it offline, and then upload and submit the application via the 
Grants.gov site. E-mail submissions will not be accepted. If you are 
having technical difficulties in Grants.gov they can be reached by E-
mail at support@grants.gov or by phone at 1-800-518-4726 (1-800-518-
GRANTS). The Customer Support Center is open from 7 a.m. to 9 p.m. 
eastern time, Monday through Friday.
    Paper Submission: If you chose to submit a paper application, 
submit the original and two hard copies of your application by mail or 
express delivery service to:
    You may submit your application electronically at: https://
www.grants.gov, OR submit the original and two hard copies of your 
application by mail or express delivery service to: Technical 
Information Management-PA AA123, CDC Procurement and Grants 
Office, 2920 Brandywine Road, Atlanta, GA 30341.

V. Application Review Information

V.1. Criteria

    Applicants are required to provide measures of effectiveness that 
will demonstrate the accomplishment of the various identified 
objectives of the cooperative agreement. Measures of effectiveness must 
relate to the performance goals stated in the ``Purpose'' section of 
this announcement. Measures must be objective and quantitative, and 
must measure the intended outcome. These measures of effectiveness must 
be

[[Page 32780]]

submitted with the application and will be an element of evaluation.
    Evaluation Criteria: The budget although not scored, will be 
reviewed. Questions to be considered include: Is the itemized budget 
for conducting the project, along with the justification, reasonable, 
and consistent with the stated objectives and planned program 
objectives?
    Your application will be evaluated against the following criteria.
    Global Disease Detection and Perinatal and Maternal Mortality 
Reduction Plan (35 Points): Is the plan adequate to carry out the 
proposed objectives?
    Does the plan cover all necessary components?
    How complete and comprehensive is the plan for the entire project 
period?
    Does this plan include quantitative process and outcome measures?
    Does the plan maintain adequate surveillance, monitoring, 
evaluation and data collection and analysis components?
    Overall Methods (20 points): Are the proposed methods feasible? To 
what extent will they accomplish the program goals?
    Overall Reach and Capacity (20 points): Eligible applicants will be 
a legal entity with approval to work and memoranda of understanding 
(MOUs) with Ministries of Health (MOH) in: Vietnam, Afghanistan, 
Ethiopia, Tajikistan, Tanzania, Kenya, and India. Initial areas of 
collaboration include these countries and therefore the grantee must 
have ten years of experience and legal authority to work in these 
countries.
    Does the applicant have demonstrated capacity in the listed 
countries?
    Does the applicant have MOUs and a minimum of ten years of 
experience in the listed countries?
    Does the eligible entity have experience of working in 
environmental health practice in Latin America?
    Does the applicant have programmatic capacity in all areas?
    Does the applicant have demonstrated ability to implement public 
health interventions internationally in resource-poor and non-
traditional settings?
    Does the applicant have experience working with disenfranchised 
populations?
    Does the applicant have worldwide reach and partnership for the 
dissemination of information, i.e., a resident staff presence in at 
least sixty countries?
    Does the applicant have sufficient community-based knowledge and 
practice?
    Does the applicant have the ability/capacity to work with local on 
the ground staff to establish programs?
    Overall Personnel (15 points): Do the staff members have the 
appropriate experience?
    Are the staff roles clearly defined?
    As described, will the staff be sufficient to accomplish the 
program goals?
    Safe Water Systems (SWS)/Environmental Health Practice/Early 
Childhood Health and Development Plan (10 Points): Is the plan adequate 
to carry out the proposed objectives?
    Does the plan cover all necessary components?
    How complete and comprehensive is the plan for the entire project 
period?
    Does this plan include quantitative process and outcome measures?
    Does the plan maintain adequate surveillance, monitoring, 
evaluation and data collection and analysis components?

V.2. Review and Selection Process

    Applications will be reviewed for completeness by the Procurement 
and Grants Office (PGO) staff, and for responsiveness by an objective 
review panel. Incomplete applications and applications that are non-
responsive to the eligibility criteria will not advance through the 
review process. Applicants will be notified that their application did 
not meet submission requirements.
    An objective review panel will evaluate complete and responsive 
applications according to the criteria listed in the ``V.1. Criteria'' 
section above. The review will occur by CDC Employees from outside the 
Office of Global Health. Applications will be funded in order by score 
and rank determined by the review panel.

V.3. Anticipated Announcement and Award Dates

    August 1, 2005.

VI. Award Administration Information

VI.1. Award Notices

    Successful applicants will receive a Notice of Award (NoA) from the 
CDC Procurement and Grants Office. The NoA shall be the only binding, 
authorizing document between the recipient and CDC. The NoA will be 
signed by an authorized Grants Management Officer, and mailed to the 
recipient fiscal officer identified in the application.
    Unsuccessful applicants will receive notification of the results of 
the application review by mail.

VI.2. Administrative and National Policy Requirements

    Successful applicants must comply with the administrative 
requirements outlined in 45 CFR Part 74 as Appropriate. For more 
information on the Code of Federal Regulations, see the National 
Archives and Records Administration at the following Internet address: 
https://www.access.gpo.gov/nara/cfr/cfr-table-search.html.
    An additional Certifications form from the PHS5161-1 application 
needs to be included in your Grants.gov electronic submission only. 
Refer to https://www.cdc.gov/od/pgo/funding/PHS5161-1Certificates.pdf. 
Once the form is filled out attach it to your Grants.gov submission as 
Other Attachments Form.
    The following additional requirements apply to this project:
     AR-4 HIV/AIDS Confidentiality Provisions.
     AR-5 HIV Program Review Panel Requirements.
     AR-6 Patient Care.
     AR-10 Smoke-Free Workplace Requirements.
     AR-12 Lobbying Restrictions.
     AR-13 Prohibition on Use of CDC Funds for Certain Gun 
Control Activities.
     AR-14 Accounting System Requirements.
     AR-15 Proof of Non-Profit Status.
    Additional information on these requirements can be found on the 
CDC Web site at the following Internet address: https://www.cdc.gov/od/
pgo/funding/ARs.htm.

VI.3. Reporting Requirements

    You must provide CDC with an original, plus two hard copies of the 
following reports:
    1. Interim progress report, due no less than 90 days before the end 
of the budget period. The progress report will serve as your non-
competing continuation application, and must contain the following 
elements:
    a. Current Budget Period Activities Objectives.
    b. Current Budget Period Financial Progress.
    c. New Budget Period Program Proposed Activity Objectives.
    d. Budget.
    e. Measures of Effectiveness.
    f. Additional Requested Information.
    2. Financial status report and annual progress report, no more than 
90 days after the end of the budget period.
    3. Final financial and performance reports, no more than 90 days 
after the end of the project period.
    These reports must be mailed to the Grants Management or Contract

[[Page 32781]]

Specialist listed in the ``Agency Contacts'' section of this 
announcement.

VII. Agency Contacts

    We encourage inquiries concerning this announcement.
    For general questions, contact: Technical Information Management 
Section, CDC Procurement and Grants Office, 2920 Brandywine Road, 
Atlanta, GA 30341. Telephone: 770-488-2700.
    For program technical assistance, contact: Aaron Rak, MA, Centers 
for Disease Control and Prevention, 1600 Clifton Road, MS D-58, 
Atlanta, Georgia 30333. Telephone: (404) 498.4486. E-mail: 
arak@cdc.gov. Patricia Riley, CNM MPH Project Officer, Office of Global 
Health, Centers for Disease Control and Prevention, 1600 Clifton Road, 
MS D-69, Atlanta, Georgia 30333. Telephone: (404) 639.1492. E-mail: 
PRiley@cdc.gov.
    For financial, grants management, or budget assistance, contact: 
Steward Nichols, Grants Management Specialist, CDC Procurement and 
Grants Office, 2920 Brandywine Road, Atlanta, GA 30341. Telephone: 770-
488-2788. E-mail: shn8@cdc.gov.

VIII. Other Information

    This and other CDC funding opportunity announcements can be found 
on the CDC Web site, Internet address: https://www.cdc.gov. Click on 
``Funding'' then ``Grants and Cooperative Agreements.''

    Dated: May 31, 2005.
William P. Nichols,
Director, Procurement and Grants Office, Centers for Disease Control 
and Prevention.
[FR Doc. 05-11152 Filed 6-3-05; 8:45 am]
BILLING CODE 4163-18-P